CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 38 enrolled
Drug / intervention
ViOptixdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05592145
NCT05592145N/ACompleted
CompareCT.gov

Quantifying the Venous Congestion Curve of a Tissue Oximetry Device

Wake Forest University Health Sciences·interventional·Posted Oct 24, 2022·Updated Mar 21, 2024

In Brief

A clinical study evaluating ViOptix for Post-Op Complication and Skin Flap Necrosis. Completed, enrolled 38 participants across 1 site.

Detailed Summary

The purpose of this research study is to measure rate of decline and pattern of tissue oxygenation using the device, ViOptix T.Ox. ViOptix probes will be secured to the arm and hand. The recording process on the ViOptix machine will begin and obtain baseline StO2 levels for 5 minutes. After 5 minutes, a blood pressure cuff will be inflated on one arm. This blood pressure cuff will be left inflated for 10-20 minutes. Every 2 minutes a pulse check or doppler exam will be performed at your wrist. Last, the cuff will be deflated and the you will be free to leave the study room.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPost-Op Complication, Skin Flap Necrosis
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2023202420252026
First PostedOct 24, 2022
Enrollment StartNov 10, 2022
Primary CompletionJun 1, 2023
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 3.7 years ago

Interventions

ViOptixdevice

ViOptix machine